Corrigendum: Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-α

• Elizabeth A. Spencer,
• Marla C. Dubinsky,
• Michael A. Kamm,
• Maria Chaparro,
• Paolo Gionchetti,
• Paolo Gionchetti,
• Fernando Rizzello,
• Fernando Rizzello,
• Javier P. Gisbert,
• Emily K. Wright,
• Julien D. Schulberg,
• Amy L. Hamilton,
• Dermot P. B. McGovern,
• Thierry Dervieux

Affiliations

Elizabeth A. Spencer

Division of Gastroenterology, Icahn School of Medicine Mount Sinai, New York, NY, United States

Marla C. Dubinsky

Division of Gastroenterology, Icahn School of Medicine Mount Sinai, New York, NY, United States

Michael A. Kamm

St Vincent’s Hospital and The University of Melbourne, Melbourne, VIC, Australia

Maria Chaparro

Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain

Paolo Gionchetti

IRCCS Azienda Ospedaliero-Universitaria di Bologna Italy, Bologna, Italy

Paolo Gionchetti

DIMEC University of Bologna-Italy, Bologna, Italy

Fernando Rizzello

IRCCS Azienda Ospedaliero-Universitaria di Bologna Italy, Bologna, Italy

Fernando Rizzello

DIMEC University of Bologna-Italy, Bologna, Italy

Javier P. Gisbert

Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain

Emily K. Wright

St Vincent’s Hospital and The University of Melbourne, Melbourne, VIC, Australia

Julien D. Schulberg

St Vincent’s Hospital and The University of Melbourne, Melbourne, VIC, Australia

Amy L. Hamilton

St Vincent’s Hospital and The University of Melbourne, Melbourne, VIC, Australia

Dermot P. B. McGovern

F. Widjaja Inflammatory Bowel Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States

Thierry Dervieux

Research and Development, Prometheus Laboratories, San Diego, CA, United States